Your browser doesn't support javascript.
loading
Corallodiscus flabellata B. L. Burtt extract and isonuomioside A ameliorate Aß25-35-induced brain injury by inhibiting apoptosis, oxidative stress, and autophagy via the NMDAR2B/CamK Ⅱ/PKG pathway.
Zeng, Mengnan; Feng, Aozi; Li, Meng; Liu, Meng; Guo, Pengli; Zhang, Yuhan; Zhang, Qinqin; Zhang, Beibei; Cao, Bing; Jia, Jufang; Wang, Ru; Lyu, Jun; Zheng, Xiaoke.
Afiliação
  • Zeng M; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou, China.
  • Feng A; Department of Clinical Research, the First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Li M; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou, China.
  • Liu M; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou, China.
  • Guo P; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou, China.
  • Zhang Y; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou, China.
  • Zhang Q; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou, China.
  • Zhang B; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou, China.
  • Cao B; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou, China.
  • Jia J; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou, China.
  • Wang R; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou, China.
  • Lyu J; Department of Clinical Research, the First Affiliated Hospital of Jinan University, Guangzhou, China. Electronic address: lyujun2020@jnu.edu.cn.
  • Zheng X; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou, China. Electronic address: zhengxk.2006@163.com.
Phytomedicine ; 101: 154114, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35489325
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lesões Encefálicas / Fármacos Neuroprotetores / Doença de Alzheimer Limite: Humans Idioma: En Revista: Phytomedicine Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lesões Encefálicas / Fármacos Neuroprotetores / Doença de Alzheimer Limite: Humans Idioma: En Revista: Phytomedicine Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China